Skip to main content
. 2021 Jul 28;26(11):2496–2501. doi: 10.1016/j.drudis.2021.06.020

Figure 2.

Figure 2

Challenges affecting the adoption of microphysiological systems (MPS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) research and drug development. MPS for COVID Research (MPSCoRe) working group members were asked to select their top three scientific (a) and practical (b) challenges/barriers affecting the use of MPS for SARS-CoV-2 research.